Yaşar Cırdı

Yaşar Cırdı

Auto-generated profile, based on publicly available information

Yaşar Cırdı

Sakarya University Training and Research Hospital, Department Anesthesiology and Reanimation, Sakarya, TR

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
AEAli Eman
Ali Eman
OBOnur Balaban
Onur Balaban
HKHavva Kocayiğit
Havva Kocayiğit
KSKezban Özmen Süner
Kezban Özmen Süner
YCYaşar Cırdı
Yaşar Cırdı
AEAli Fuat Erdem
Ali Fuat Erdem
Eman A, et al. J Korean Med Sci. 2021 Nov;36(44):e309. https://doi.org/10.3346/jkms.2021.36.e309

29 April 2024 in Medical Science and Discovery
Verified
Journal Article
Open access
PDF file
KSKezban Özmen Süner
Kezban Özmen Süner
YCYaşar Cırdı
Yaşar Cırdı
HKHavva Kocayiğit
Havva Kocayiğit
HDHamad Dheir
Hamad Dheir
SYSelcuk Yaylaci
Selcuk Yaylaci
AEAli Fuat Erdem
Ali Fuat Erdem
Objective: This study aims to examine the impact of low-dose and high-dose corticosteroids on the clinical outcomes and mortality of critically ill patients with COVID-19 in intensive care units. Material and Methods: This study was conducted on 197 confirmed COVID-19 patients who received corticosteroid therapy in the intensive care unit (ICU) between June 1st and December 31st, 2020. Patients were divided into two groups for low- and high-dose corticosteroid therapy. Both groups were compared according to demographic features, comorbid conditions, laboratory parameters, as well as the ordinal scale for clinical improvement (OSCI), hospital mortality, and length of stay in the intensive care unit. Results: A total of 140 patients received low-dose corticosteroids, while 57 patients received high-dose corticosteroid therapy. Our findings revealed a significantly higher median length of stay in the ICU and mortality in the group that received high-dose corticosteroid therapy. We observed a significant reduction in ferritin and D-dimer levels in the group receiving high-dose corticosteroid therapy (p < 0.003, p < 0.012, respectively). Furthermore, OSCIs on admission, day 5, and day 10 after corticosteroid therapy were higher in the group receiving high-dose corticosteroids. Conclusion: The results of this study indicate that high-dose corticosteroid therapy in critically ill patients with COVID-19 is associated with high mortality rates and prolonged intensive care stays.

27 March 2021
Verified
Book Chapter
Closed access
KSKezban Özmen Süner
Kezban Özmen Süner
YCYaşar Cırdı
Yaşar Cırdı